The report Hemostats and Tissue Sealants Market by product type (hemostats [Flowable hemostats, Mechanical hemostats, Active
hemostats] and tissue sealants [synthetic sealants, fibrin sealants and other natural sealants]) - Global Industry Analysis, Trends analysis
and Forecast up to 2023 studies the world as well as regional markets including North America, Europe, Asia Pacific and RoW (Including
Latin America, Middle East and Africa), The Hemostats and Tissue Sealants market is expected to grow at a CAGR of 8.71% over the
period of 2018 to 2024. Factors driving the growth of this market include rising number of surgeries, focus on fast recovery of the patients
and increased availability of the medical professionals worldwide, however regulatory hurdles and low effectiveness of hemostats and
tissue sealing in some cases are key restraining factors affecting the growth of the global hemostats and tissue sealing market over the
forecast period.
Get Free Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/789
Development of new hemostats and tissues sealants to be a key trend in the hemostats and tissue sealants market
The companies operating in the global hemostats and tissues sealants market have been engaged in developing new hemostats and
tissue sealants. The development of new tissue sealants is aimed at minimizing the cases of contamination and side effects associated
with the tissue sealing. Companies such as Novartis and Baxter are engaged in developing the new tissue sealants to be more
competitive.
Fibrin sealants to account for largest share of revenue generated in tissue sealants market
Tissue sealant segment covers sub segments such as synthetic sealants, fibrin sealants, and other natural sealants. The fibrin sealants
segment accounted for over 80% of the revenue generated from the tissue sealants market worldwide. Fibrin sealants help in reducing
clotting time and blood loss during the surgical procedures. Moreover these prevent risk of infections and aid in would healing process.
The US FDA has approved fibrin sealants as broad level hemostats for surgical procedures.